BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9822144)

  • 1. Calcium antagonists and the diabetic patient: a response to recent controversies.
    Poulter NR
    Am J Cardiol; 1998 Nov; 82(9B):40R-41R. PubMed ID: 9822144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists and cardiovascular risk in diabetes.
    Parving HH
    Am J Cardiol; 1998 Nov; 82(9B):42R-44R. PubMed ID: 9822145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET).
    Sowers JR
    Am J Cardiol; 1998 Nov; 82(9B):15R-19R. PubMed ID: 9822138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?
    Grossman E; Messerli FH; Goldbourt U
    Arch Intern Med; 2000 Sep; 160(16):2447-52. PubMed ID: 10979055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on calcium antagonists and the kidney.
    Tobe S
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
    Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
    Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Gasowski J; Birkenhäger WH; Staessen JA; de Leeuw PW
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):49-53. PubMed ID: 10755200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
    Locatelli F; Del Vecchio L; Andrulli S; Colzani S
    Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
    Estacio RO; Schrier RW
    Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diabetic patients with hypertension.
    Birkenhäger WH; Staessen JA
    Curr Hypertens Rep; 1999 Jun; 1(3):225-31. PubMed ID: 10981070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertensive patients with diabetes.
    Pahor M; Psaty BM; Furberg CD
    Lancet; 1998 Mar; 351(9104):689-90. PubMed ID: 9504510
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.